All lobbying filings
MADRIGAL PHARMACEUTICALS, INC.
Lobbying for MADRIGAL PHARMACEUTICALS, INC. · Biopharmaceutical company
Filing
3rd Quarter - Amendment
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Dec 4, 2025
Expenses
$30,000.00
What this organization spent lobbying with its own staff.
Reported using A: the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Pennsylvania
Lobbying activity
1
Most Favored Nation drug pricing